New Nirogacestat Combos to Enter Myeloma Trials, SpringWorks Says
News
SpringWorks Therapeutics announced new collaborations with two companies, Pfizer and Janssen, to investigate its oral therapy candidate nirogacestat in combination with BCMA-targeting agents to treat people with relapsed or refractory multiple ... Read more